Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38589859)

  • 1. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
    Jiang J; Lu Y; Chu J; Zhang X; Xu C; Liu S; Wan Z; Wang J; Zhang L; Liu K; Liu Z; Yang A; Ren X; Zhang R
    J Nanobiotechnology; 2024 Apr; 22(1):159. PubMed ID: 38589859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer.
    Li Z; Yang L; Wang H; Binzel DW; Williams TM; Guo P
    Nucleic Acid Ther; 2021 Oct; 31(5):364-374. PubMed ID: 33999716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo.
    Zhou Z; Wu X; Zhan R; Li X; Cheng D; Chen L; Wang T; Yu H; Zhang G; Tang X
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36224722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
    Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
    Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
    Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer.
    Rao DY; Huang DF; Si MY; Lu H; Tang ZX; Zhang ZX
    Front Immunol; 2023; 14():1142539. PubMed ID: 37122754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer.
    Nie H; Xie X; Zhang D; Zhou Y; Li B; Li F; Li F; Cheng Y; Mei H; Meng H; Jia L
    Nanoscale; 2020 Jan; 12(2):877-887. PubMed ID: 31833519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.
    Li X; Wang Y; Wang J; Zhang T; Zheng L; Yang Z; Xing L; Yu J
    Int J Cancer; 2018 Jul; 143(1):212-224. PubMed ID: 29430654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.
    Saruwatari K; Ikeda T; Saeki S; Shingu N; Imamura K; Komatu T; Ushijima S; Maruyama H; Kashiwabara K; Tomita Y; Ichiyasu H; Fujii K; Sakagami T
    Anticancer Res; 2019 Feb; 39(2):923-931. PubMed ID: 30711977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p/EPB41L5 axis to promote non-small cell lung cancer brain metastasis.
    Wu D; Deng S; Li L; Liu T; Zhang T; Li J; Yu Y; Xu Y
    Cell Death Dis; 2021 Jul; 12(8):721. PubMed ID: 34285192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy.
    Garbuzenko OB; Kuzmov A; Taratula O; Pine SR; Minko T
    Theranostics; 2019; 9(26):8362-8376. PubMed ID: 31754402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG
    Man RCH; Qiu Y; Leung SWS; Fruhwirth GO; Lam JKW
    Eur J Pharm Biopharm; 2024 Feb; 195():114177. PubMed ID: 38185193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis.
    Zhu Y; Liu C; Xu Z; Zou Z; Xie T; Xing P; Wang L; Li J
    Chin Med J (Engl); 2023 Nov; 136(21):2551-2561. PubMed ID: 37160733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth.
    Lu Y; Wang Y; Zhang M; Liu L; Li F; Zhang J; Ye M; Zhao H; Zhao J; Yan B; Yang A; Zhang R; Li X; Ren X
    Oncotarget; 2016 Apr; 7(17):23594-607. PubMed ID: 26988752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR
    Yin W; Zhao Y; Kang X; Zhao P; Fu X; Mo X; Wang Y; Huang Y
    Theranostics; 2020; 10(14):6122-6135. PubMed ID: 32483443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circZCCHC6 contributes to tumorigenesis by regulating LPCAT1 via miR-433-3p in non-small cell lung cancer.
    Guo Y; Xue W; Sun S; Chen X; Li H; Yan C
    Clin Exp Med; 2022 Nov; 22(4):647-659. PubMed ID: 35089454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer.
    Wu S; Luo M; To KKW; Zhang J; Su C; Zhang H; An S; Wang F; Chen D; Fu L
    Mol Cancer; 2021 Jan; 20(1):17. PubMed ID: 33461557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.